Table 1 Clinicopathological features of CC patients in test and train group.

From: Identification of cuproptosis-related lncRNA for predicting prognosis and immunotherapeutic response in cervical cancer

Covariates

Type

Total (n = 304)

Test (n = 152)

Train (n = 152)

P value

Age (years), n (%)

≤ 50

186 (61.18)

98 (64.47)

88 (57.89)

0.2895

> 50

118 (38.82)

54 (35.53)

64 (42.11)

Grade, n (%)

G1-2

153 (50.33)

76 (50)

77 (50.66)

0.691

G3-4

119 (39.14)

57 (37.5)

62 (40.79)

Unknown

32 (10.53)

19 (12.5)

13 (8.55)

T, n (%)

T1-2

211 (69.41)

110 (72.37)

101 (66.45)

0.9973

T3-4

30 (9.87)

15 (9.87)

15 (9.87)

Unknown

63 (20.72)

27 (17.76)

36 (23.68)

M, n (%)

M0

116 (38.16)

61 (40.13)

55 (36.18)

0.664

M1

10 (3.29)

4 (2.63)

6 (3.95)

Unknown

178 (58.55)

87 (57.24)

91 (59.87)

N, n (%)

N0

133 (43.75)

65 (42.76)

68 (44.74)

0.527

N1

60 (19.74)

33 (21.71)

27 (17.76)

Unknown

111 (36.51)

54 (35.53)

57 (37.5)